| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0005 |